Skip to main content
Log in

Opioid use prior to total hip arthroplasty leads to worse clinical outcomes

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to compare the clinical outcomes of patients undergoing total hip arthroplasty (THA) who had been using narcotic medications prior to surgery to those who had not used them.

Methods

Fifty-four patients (62 hips) who had required opioid analgesia for hip pain in the three months prior to THA were compared to a matched group of opioid-naïve patients. Narcotic consumption was converted to a standardized morphine equivalent dose and compared between both groups of patients during their hospital stay, after six weeks, and at final follow-up. Other outcome measures included clinical outcome scores and the proportion of patients remaining on narcotic pain medication at final follow-up.

Results

The narcotic group required significantly higher total daily opioid doses as inpatients had a longer hospital stay and a higher proportion of patients who remained on opioids at six weeks and at final follow-up. Of the patients who were taking opioids pre-operatively, 81 % were able to wean off opioids at final follow-up. At a mean post-operative follow-up of 58 months (range, 24–258 months), Harris hip scores were lower in the narcotic group, with a mean of 84 compared to 91 points in the matching group. However, in both cohorts, there were significant improvements in Harris hip scores compared to pre-operative outcomes.

Conclusions

Patients who use narcotics prior to total hip arthroplasty may be more likely to suffer from opioid-induced hyperalgesia after surgery and have worse clinical outcomes. When possible, efforts should be made to use other modes of analgesia or wean patients from their use prior to total hip arthroplasty.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58(1):26

    Article  PubMed Central  PubMed  Google Scholar 

  2. Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15

    PubMed  Google Scholar 

  3. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons (2009) Pharmacological management of persistent pain in older persons. Pain Medicine 10(6):1062

    Article  Google Scholar 

  4. Gloth FM (2011) Pharmacological management of persistent pain in older persons: focus on opioids and nonopioids. J Pain 12(3 Suppl 1):S14

    Article  CAS  PubMed  Google Scholar 

  5. Zhang W, Moskowitz RW, Nuki G et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16(2):137

    Article  CAS  PubMed  Google Scholar 

  6. Jordan KM, Arden NK, Doherty M et al (2003) Standing Committee for International Clinical Studies Including Therapeutic Trials E. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Glauser TA, Salinas GD, Roepke NL et al (2011) Management of mild-to-moderate osteoarthritis: a study of the primary care perspective. Postgrad Med 123(1):126

    Article  PubMed  Google Scholar 

  8. Webster BS, Verma SK, Gatchel RJ et al (2007) Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use. Spine (Phila Pa 1976) 32(19):2127

    Article  Google Scholar 

  9. Lawrence JT, London N, Bohlman HH et al (2008) Preoperative narcotic use as a predictor of clinical outcome: results following anterior cervical arthrodesis. Spine (Phila Pa 1976) 33(19):2074

    Article  Google Scholar 

  10. Lee M, Silverman SM, Hansen H et al (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14(2):145

    PubMed  Google Scholar 

  11. Guignard B, Bossard AE, Coste C et al (2000) Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93(2):409

    Article  CAS  PubMed  Google Scholar 

  12. Chia YY, Liu K, Wang JJ et al (1999) Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth 46(9):872

    Article  CAS  PubMed  Google Scholar 

  13. Ready LB (1996) Postoperative pain management–beyond basics. Can J Anaesth 43(2):193

    Article  CAS  PubMed  Google Scholar 

  14. Jamison RN, Taft K, O'Hara JP et al (1993) Psychosocial and pharmacologic predictors of satisfaction with intravenous patient-controlled analgesia. Anesth Analg 77(1):121

    CAS  PubMed  Google Scholar 

  15. Lee A, Tsang CK, Siu HK et al (2008) Management of osteoarthritic pain in Hong Kong. Aust Fam Physician 37(10):874

    PubMed  Google Scholar 

  16. Chu LF, Clark DJ, Angst MS et al (2006) Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7(1):43

    CAS  PubMed  Google Scholar 

  17. Pereira J, Lawlor P, Vigano A et al (2001) Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage 22(2):672

    Article  CAS  PubMed  Google Scholar 

  18. American Pain Society (2003) Principles of analgesic use in the treatment of acute pain and cancer pain. American Pain Society, Glenview, p 74

    Google Scholar 

  19. Chou R, Fanciullo GJ, Fine PG et al (2009) American Pain Society-American Academy of Pain Medicine Opioids Guidelines P. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 10(2):113

    Article  CAS  PubMed  Google Scholar 

  20. Pergolizzi J, Boger RH, Budd K et al (2008) Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8(4):287

    Article  PubMed  Google Scholar 

  21. Amstutz HC, Thomas BJ, Jinnah R et al (1984) Treatment of primary osteoarthritis of the hip. A comparison of total joint and surface replacement arthroplasty. J Bone Joint Surg Am 66(2):228

    CAS  PubMed  Google Scholar 

  22. Harris WH (1986) Etiology of osteoarthritis of the hip. Clin Orthop Rel Res 213:20

    Google Scholar 

  23. Carragee EJ, Alamin TF, Miller JL et al (2005) MRI and psychosocial determinants of low back pain disability and remission: a prospective study in subjects with benign persistent back pain. Spine J 5(1):24

    Article  PubMed  Google Scholar 

  24. Buer N, Linton SJ (2002) Fear-avoidance beliefs and catastrophizing: occurrence and risk factor in back pain and ADL in the general population. Pain 99(3):485

    Article  PubMed  Google Scholar 

  25. IJzelenberg W, Burdorf A (2005) Risk factors for musculoskeletal symptoms and ensuing health care use and sick leave. Spine (Phila Pa 1976) 30(13):1550

    Article  CAS  Google Scholar 

  26. Singh JA, Lewallen D (2009) Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol 28(12):1419

    Article  PubMed Central  PubMed  Google Scholar 

  27. Jordan JM, Linder GF, Renner JB et al (1995) The impact of arthritis in rural populations. Arthritis Care Res 8(4):242

    Article  CAS  PubMed  Google Scholar 

  28. Franklin PD, Karbassi JA, Li W et al (2010) Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction. J Arthroplasty 25(6 Suppl):12

    Article  PubMed  Google Scholar 

  29. Post ZD, Restrepo C, Kahl LK et al (2010) A prospective evaluation of 2 different pain management protocols for total hip arthroplasty. J Arthroplasty 25(3):410

    Article  PubMed  Google Scholar 

  30. Busch CA, Whitehouse MR, Shore BJ et al (2010) The efficacy of periarticular multimodal drug infiltration in total hip arthroplasty. Clin Orthop Rel Res 468(8):2152

    Article  Google Scholar 

  31. Kahl L, Parvizi J, Viscusi ER et al (2010) Lessons learned with extended-release epidural morphine after total hip arthroplasty. Clin Orthop Rel Res 468(4):1082

    Article  Google Scholar 

  32. Frassanito L, Rodola F, Concina G et al (2008) The efficacy of the psoas compartment block versus the intrathecal combination of morphine, fentanyl and bupivacaine for postoperative analgesia after primary hip arthroplasty: a randomized single-blinded study. Eur Rev Med Pharmacol Sci 12(2):117

    CAS  PubMed  Google Scholar 

  33. Kidner CL, Mayer TG, Gatchel RJ et al (2009) Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am 91(4):919

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Disclosures

RP is a paid consultant for DJO.

BHK is a consultant for Sage products Inc.

PMB receives royalties from Arthrocare; Stryker; Synthes; Biomet; Joint Active Systems, Inc., Acacia Research Group, LLC, is a consultant for Stryker and Biomet, and has Stock or Stock options in Joint Active Systems, Inc.

MAM receives royalties from Stryker Orthopaedics; is a paid consultant for Johnson & Johnson, Sage Products, Medtronic, TissueGene, Stryker Orthopaedics, OnGoing Care Solutions, Inc. and Wright Medical Technologies, Inc.; and receives research support from National Institutes of Health (NIAMS and NICHD), Sage Products, Stryker Orthopaedics, TisseGene, and Wright Medical Technologies, Inc.

KI and QN have no disclosures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael A. Mont.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pivec, R., Issa, K., Naziri, Q. et al. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. International Orthopaedics (SICOT) 38, 1159–1165 (2014). https://doi.org/10.1007/s00264-014-2298-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-014-2298-x

Keywords

Navigation